Nomad Foods Reports Q4 & FY25 Declines, Issues Negative FY26 Guidance; CEO Plans Open-Market Share Purchase
NOMD is trading near its 52-week low of $11.04 (8.7% above the low).
Summary
Nomad Foods reported Q4 and full-year 2025 financial results with declines in key metrics and issued negative guidance for 2026, anticipating a 'transition year' as it implements strategic changes. The CEO expressed confidence and plans an open-market share purchase.
Key Events · Earnings and Guidance · NOMD
-
Q4 & Full Year 2025 Financial Performance
Reported revenue decreased 2.6% to €773 million in Q4 and 2.2% to €3.0 billion for the full year. Reported profit declined significantly due to €57 million in debt refinancing losses. Adjusted EBITDA decreased 4.7% in Q4 and 7.5% for the full year. Adjusted EPS increased 2.4% in Q4 but decreased 6.7% for the full year.
-
Negative FY26 Guidance Issued
For fiscal year 2026, the company expects organic revenue to decline by 2%-5%, Adjusted EBITDA to decline by 5%-10%, and Adjusted EPS to be €1.45-€1.60, implying a 4-13% decline. Management describes 2026 as a 'transition year'.
-
CEO Plans Open-Market Share Purchase
CEO Dominic Brisby stated his intent to make a 'sizable open-market purchase' of Nomad shares in the coming weeks to express confidence and align interests with shareholders, despite the anticipated transition year.
-
Shareholder Returns and Share Count Reduction
The company returned €287 million to shareholders in 2025 through dividends and share repurchases, resulting in a 9% decrease in basic shares outstanding from year-end 2024.
Analysis · NOMD · Manufacturing
Nomad Foods reported a challenging fourth quarter and full year 2025, with declines in reported revenue, profit, and Adjusted EBITDA. While Q4 Adjusted EPS saw a modest increase, full-year Adjusted EPS decreased. The company's 2026 guidance projects further declines in organic revenue, Adjusted EBITDA, and Adjusted EPS, signaling a 'transition year' as management implements foundational changes. A significant one-time loss of €57 million from debt refinancing impacted reported profit and EPS in Q4 and the full year. Despite the negative financial outlook, the CEO's stated intent to make a sizable open-market purchase of shares in the coming weeks provides a potential vote of confidence, aligning management's interests with shareholders during this period of strategic overhaul.
At the time of this filing, NOMD was trading at $12.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $11.04 to $20.81. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.